Phenotypic age calculator

Reading the gap, not the number

The informative output is the difference between your phenotypic age and your actual age, which the literature calls age acceleration. In NHANES, each year of positive age acceleration was associated with higher all-cause mortality risk, independent of chronological age.

• Two or more years younger: PhenoAge at least 2 years below your age. Your nine markers look better than average for your age. Useful as a baseline to defend rather than as a result to celebrate once.
• Around your chronological age: Within 2 years either way. Average for your age. Worth looking at which individual markers are pulling in each direction, since a normal total can hide one outlier.
• Two to five years older: 2 to 5 years above your age. Mild acceleration. In most people this is driven by inflammation, glucose or red cell distribution width rather than by all nine markers at once.
• More than five years older: Over 5 years above your age. Worth a proper look at the individual markers with a clinician. Acute illness or infection at the time of the draw can produce this on its own, so repeat before drawing conclusions.

What this actually calculates

Levine and colleagues fitted a Gompertz mortality model in NHANES III using 42 candidate clinical measures and, after cross-validation, kept nine plus chronological age. The output of that model is a 10 year mortality probability, which is then converted back into the age at which the average person carries that same risk.

So phenotypic age is a translation of mortality risk into years. That is why it is more informative than the individual markers, and also why it should not be read as a measurement of how old your cells are.

In the validation work, phenotypic age outperformed chronological age and the individual clinical measures for predicting mortality, with a reported area under the curve of 0.88 against 0.86 for chronological age alone.

• Nine markers: albumin, creatinine, glucose, log C-reactive protein, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase, white blood cell count.
• Plus chronological age, which carries the largest single weight in the model.
• Trained in NHANES III (n = 9,926) and validated in NHANES IV.
• Published in Levine et al., Aging, 2018, with the coefficients in Supplementary Table S1.

The formula, in full

There is no reason to hide this. The linear predictor is the sum of each marker multiplied by its published coefficient, in the units the model was fitted in, plus a constant of -19.90667.

That predictor goes into the Gompertz cumulative distribution function to give a 120 month mortality probability M, using the published gamma of 0.0076927. The final step converts M into years: phenotypic age = 141.50225 + ln(-0.00553 x ln(1 - M)) / 0.090165.

The coefficients expect SI units, which is why this page asks which units your report uses and converts before calculating. Several public calculators apply the SI coefficients directly to US values, which produces a confidently wrong answer, most visibly for albumin and glucose.

• Albumin g/L: -0.0336. Creatinine µmol/L: 0.0095. Glucose mmol/L: 0.1953.
• Log C-reactive protein in mg/dL: 0.0954. Lymphocyte percent: -0.0120.
• Mean cell volume fL: 0.0268. Red cell distribution width percent: 0.3306.
• Alkaline phosphatase U/L: 0.00188. White blood cell count 1000/µL: 0.0554. Age: 0.0804.
• Conversions used here: albumin g/dL x 10, creatinine mg/dL x 88.4, glucose mg/dL divided by 18.016, C-reactive protein mg/L divided by 10 before taking the natural log.

Which markers move it, and how much

Red cell distribution width carries the largest coefficient of the nine biomarkers, so a value of 15 percent instead of 12.5 percent shifts the estimate meaningfully on its own. Glucose is next in practical terms, then inflammation through C-reactive protein.

That has an obvious consequence for how you interpret a result. A single high reading in one heavily weighted marker can add years, and red cell distribution width rises with iron, B12 and folate deficiency as well as with chronic disease, none of which is aging in any meaningful sense.

It also means the modifiable levers are the familiar ones. Glucose, inflammation and albumin all respond to nutrition, alcohol, training and sleep, and correcting an iron or B12 deficiency can change the estimate without anything about your aging having changed at all.

How to use it without fooling yourself

Draw fasted, in a stable period, not during or shortly after an illness. C-reactive protein and white cell count respond sharply to infection, and a viral illness in the week before your draw can add years to the estimate and then remove them at the next test.

Use the same lab where you can. Between-assay differences in albumin and alkaline phosphatase are small but not zero, and a trend across three panels from one lab is worth far more than a single number.

Then treat the direction as the finding, not the value. If your estimate falls by two years after six months of real changes to training, alcohol and sleep, that is meaningful. Chasing a single reading is how people end up treating a lab report instead of a body.

Where this number is misleading

• It is a mortality risk model expressed in years, not a measurement of biological age. Two people with identical estimates can differ in every way that matters clinically.
• It was derived in a US population aged 20 and over, so it is not applied here outside that age range, and performance in other populations is less established.
• Acute illness, dehydration, recent hard training, pregnancy and iron or B12 deficiency all move the inputs without changing anything about aging.
• Red cell distribution width carries a large weight, which makes the estimate sensitive to one marker that has many benign explanations.
• This is not epigenetic age. DNA methylation clocks, including the DNAm version from the same paper, measure something different and do not agree closely with this.
• It is educational. It cannot diagnose anything, and no treatment decision should rest on it.

Common questions

What is phenotypic age?

Phenotypic age, or PhenoAge, is the chronological age at which the average person in the reference population carries the same 10 year mortality risk as your nine blood markers imply. It is a validated research measure from Levine et al., 2018, expressed in years.

What blood tests do I need for a phenotypic age calculation?

Albumin, creatinine, fasting glucose, C-reactive protein, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase and white blood cell count. A standard complete blood count with differential plus a comprehensive metabolic panel and a CRP covers all nine.

Is phenotypic age the same as biological age?

Phenotypic age is one specific estimate of biological age built from routine blood markers. Other approaches, including DNA methylation clocks, measure something different and do not agree closely with it, so a single number labeled biological age means little without knowing which method produced it.

Why does my result differ from another calculator?

Almost always units. The published coefficients were fitted in SI units, so albumin in g/dL, creatinine in mg/dL and glucose in mg/dL have to be converted first, and C-reactive protein has to be converted from mg/L to mg/dL before the log is taken. Calculators that skip those steps produce results that are wrong in a consistent direction.

Can I lower my phenotypic age?

The inputs are modifiable, so the estimate can move. Glucose, C-reactive protein and albumin respond to nutrition, alcohol, training and sleep, and correcting an iron or B12 deficiency can change red cell distribution width. Whether that reflects slower aging or a better looking blood panel is a question the measure itself cannot answer.

Sources and disclosures

• Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging, 2018, including Supplementary Table S1 with the Gompertz coefficients used here
• Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLOS Medicine, 2018, and the 2019 correction
• Levine ME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? Journals of Gerontology, 2013
• Kwon D, Belsky DW. BioAge: an R package for computing biological ages, used here to check this implementation against the authors' own reference code
• These calculators are for education. They do not diagnose, they do not replace testing, and they are not a prescription. Baseline is a wellness consultancy, and any prescription is written by an independent licensed provider in our network who has reviewed your history, your goals and any lab work you choose to share.